#34: FastFun: Wall Street Reporter Features Exclusive Video Interviews with CEO's of BioMS Medical Corp., RegeneRx Biopharmaceuticals, Inc., and Canopus BioPharma
NEW YORK, Nov. 23, 2007 (PRIME NEWSWIRE) -- Wall Street Reporter... |
December 13, 2007
07:11:50 AM |
#33: FastFun: German and U.S. Researchers Show TB4's Cardioprotective Effects in Ischemia-Reperfusion Injury
Porcine Data Presented at American Heart Association Meeting
REGENERX... |
December 13, 2007
07:11:24 AM |
#32: FastFun: RegeneRx Receives First Ophthalmic Wound-Healing Patent in China
REGENERX BIOPHARMACEUTICALS, INC. (AMEX:RGN) (www.regenerx.com)... |
December 13, 2007
07:10:50 AM |
#31: StockPro: Interview with J.J. Finkelstein
CEO of RegeneRx Biopharmaceuticals, Inc. J.J. Finkelstein's interview is now... |
April 5, 2007
02:59:33 PM |
#30: NewsBot: RGN News RegeneRx Biopharmaceuticals, Inc. Reports 2006 Year-End Results
BETHESDA, Md.--(BUSINESS WIRE)--REGENERX BIOPHARMACEUTICALS, INC. (AMEX: RGN),... |
April 2, 2007
05:30:00 AM |
#29: NewsBot: RGN News RegeneRx Files IND to Begin Phase 2 Ophthalmic Clinical Trial
BETHESDA, Md.--(BUSINESS WIRE)--REGENERX BIOPHARMACEUTICALS, INC. (AMEX:RGN)... |
March 30, 2007
07:00:00 AM |
#28: NewsBot: RGN News RegeneRx Files First IND for Cardiovascular Clinical Program
BETHESDA, Md.--(BUSINESS WIRE)--REGENERX BIOPHARMACEUTICALS, INC. (AMEX:RGN)... |
March 30, 2007
06:04:00 AM |
#27: NewsBot: RGN News RegeneRx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year End 2006 Earnings Release and Conference Call
BETHESDA, Md.--(BUSINESS WIRE)--REGENERX BIOPHARMACEUTICALS, INC. (AMEX:RGN),... |
March 27, 2007
11:53:00 AM |
#26: NewsBot: RGN News RegeneRx Reports Preliminary Cardiovascular Data at Thymosin Meeting
BETHESDA, Md.--(BUSINESS WIRE)--REGENERX BIOPHARMACEUTICALS, INC. (AMEX:RGN)... |
March 26, 2007
05:30:00 AM |
#25: NewsBot: RGN News RegeneRx to Present at First Annual Symposium on Thymosins in Health and Disease
BETHESDA, Md.--(BUSINESS WIRE)--REGENERX BIOPHARMACEUTICALS, INC. (AMEX:RGN)... |
March 19, 2007
06:08:00 AM |
#24: NewsBot: RGN News Researchers Find that TB4 Increases Gene Expression of Key Wound Healing Enzyme in the Cornea
BETHESDA, Md.--(BUSINESS WIRE)--RegeneRx Biopharmaceuticals, Inc. (Amex:RGN)... |
March 12, 2007
05:03:00 AM |
#23: NewsBot: RGN News RegeneRx Receives First Patent for Treating Wounds and Other Disorders of the Eye
BETHESDA, Md.--(BUSINESS WIRE)--RegeneRx Biopharmaceuticals, Inc. (Amex:RGN)... |
March 6, 2007
08:57:00 AM |
#22: NewsBot: RGN News Dr. Deepak Srivastava Joins RegeneRx Medical and Scientific Advisory Board
BETHESDA, Md.--(BUSINESS WIRE)--REGENERX BIOPHARMACEUTICALS, INC. (Amex:RGN)... |
March 5, 2007
05:30:00 AM |
#21: NewsBot: RGN News Researchers Find RegeneRx's TB4 Inhibits Activation of Key Inflammatory Molecule - NFkB
BETHESDA, Md.--(BUSINESS WIRE)--RegeneRx Biopharmaceuticals, Inc. (Amex:RGN)... |
January 23, 2007
09:45:00 AM |
#20: NewsBot: RGN News RegeneRx to Present at the American Stock Exchange's First Annual Healthcare Investor Conference
BETHESDA, Md.--(BUSINESS WIRE)--RegeneRx Biopharmaceuticals, Inc. (Amex:RGN)... |
January 23, 2007
06:00:00 AM |
| 
| 
| 
| 
| 
| 
